Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

U.S. patent issues for Regeneron's Ang2 protein

Oct. 26, 1998

Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999

Oct. 23, 1998

Takeda discontinues further development of osteoporosis drug

Oct. 23, 1998

Weight-loss drugs: some disappoint, others look more promising

Oct. 22, 1998

Amylin announces positive phase I trial results for diabetes compound

Oct. 22, 1998

Phase II study of BB-10010 for maintaining hematopoiesis in patients undergoing chemotherapy

Oct. 22, 1998

Propionic acid derivatives from Nippon Chemiphar useful for diabetes and related disorders

Oct. 21, 1998

Daiichi's new squalene synthase inhibitors

Oct. 21, 1998

HMG-CoA reductase inhibitor now under regulatory review in Japan

Oct. 21, 1998

Yamanouchi applies for approval of oral bisphosphonate in Japan

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...